SCHEMBL1463946

SCHEMBL1463946

CCOC(=O)c1c[nH]c(=O)c2c(C)csc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
GAA P10253 3/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
GABRB1 P18505 1/20 0.42
GABRA3 P34903 1/20 0.42
CLEC4M Q9H2X3 1/20 0.42
KDM4E B2RXH2 5/20 0.41
GLA P06280 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359436 0.78 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL18639718 0.74 PDPK1 (0.40) CYP1A2
SCHEMBL13764548 0.73 PDPK1 (0.44) GAAKDM4E
SCHEMBL14988458 0.72 MAPT (0.56) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL15333212 0.72 KMT2A (0.53) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL1463621 0.71 KMT2A (0.43) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL26214803 0.71 ALDH1A1 (0.58) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL21776563 0.70 KMT2A (0.50) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL15413118 0.70 KMT2A (0.54) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL31549256 0.70 GABRA1 (0.49) CYP1A2CYP3A4CYP2C19KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256154-A1 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides LUK KIN-CHUN 2005-11-17 US claimed
EP-1926737-B1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2017-03-15 EP disclosed
EP-1926737-B1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2017-03-15 EP disclosed
US-7994321-B2 Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US disclosed
US-20110071147-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES LUK KIN-CHUN 2011-03-24 US disclosed
US-20110071147-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES LUK KIN-CHUN 2011-03-24 US disclosed
CN-101263145-A 4-amino-thieno [3, 2-C ] pyridine-7-carboxylic acid derivatives HOFFMANN LA ROCHE (CH) 2008-09-10 CN disclosed
EP-1926737-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-06-04 EP disclosed
EP-1917015-A1 NOVEL 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES F.HOFFMANN-LA ROCHE AG (CH) 2008-05-07 EP disclosed
US-20080045562-A1 Substituted Thieno[3,2-C]Pyridine-7-Carboxylic Acid Derivatives BARTKOVITZ DAVID JOSEPH 2008-02-21 US disclosed
WO-2008017594-A1 THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-02-14 WO disclosed
WO-2007031428-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-03-22 WO disclosed
WO-2007031428-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-03-22 WO disclosed
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BARTKOVITZ DAVID J 2007-03-15 US disclosed
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BARTKOVITZ DAVID J 2007-03-15 US disclosed
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BARTKOVITZ DAVID J 2007-03-15 US disclosed
WO-2007019884-A1 NOVEL 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2007-02-22 WO disclosed
WO-2007019884-A1 NOVEL 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2007-02-22 WO disclosed
US-20050256154-A1 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides LUK KIN-CHUN 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256154-A1 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides FGFR3, FGFR4, FGFR1 CYP1A2 1410/4885CYP3A4 735/4885CYP2C19 499/4885
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BRAF, RAF1, MAP3K7 CYP1A2 1747/4885CYP3A4 2697/4885CYP2C19 2276/4885
US-20080045562-A1 Substituted Thieno[3,2-C]Pyridine-7-Carboxylic Acid Derivatives UQCRB, RECQL, HCCS CYP1A2 762/4885CYP3A4 1310/4885CYP2C19 941/4885
US-20110071147-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES FGFR3, FGFR4, FGFR1 CYP1A2 1410/4885CYP3A4 735/4885CYP2C19 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.